Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor.

Maher TM, Simpson JK, Porter JC, Wilson FJ, Chan R, Eames R, Cui Y, Siederer S, Parry S, Kenny J, Slack RJ, Sahota J, Paul L, Saunders P, Molyneaux PL, Lukey PT, Rizzo G, Searle GE, Marshall RP, Saleem A, Kang'ombe AR, Fairman D, Fahy WA, Vahdati-Bolouri M.

Respir Res. 2020 Mar 26;21(1):75. doi: 10.1186/s12931-020-01339-7.

2.

Preclinical evaluation of [18F]FB-A20FMDV2 as a selective marker for measuring αVβ6 integrin occupancy using positron emission tomography in rodent lung.

Onega M, Parker CA, Coello C, Rizzo G, Keat N, Ramada-Magalhaes J, Moz S, Tang SP, Plisson C, Wells L, Ashworth S, Slack RJ, Vitulli G, Wilson FJ, Gunn R, Lukey PT, Passchier J.

Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):958-966. doi: 10.1007/s00259-019-04653-5. Epub 2020 Jan 3.

3.

Reproducibility of compartmental modelling of 18F-FDG PET/CT to evaluate lung inflammation.

Vass LD, Lee S, Wilson FJ, Fisk M, Cheriyan J, Wilkinson I.

EJNMMI Phys. 2019 Dec 16;6(1):26. doi: 10.1186/s40658-019-0265-8.

4.

Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study).

Lukey PT, Coello C, Gunn R, Parker C, Wilson FJ, Saleem A, Garman N, Costa M, Kendrick S, Onega M, Kang'ombe AR, Listanco A, Davies J, Ramada-Magalhaes J, Moz S, Fahy WA, Maher TM, Jenkins G, Passchier J, Marshall RP.

Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):967-979. doi: 10.1007/s00259-019-04586-z. Epub 2019 Dec 9.

5.

A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis.

Lukey PT, Harrison SA, Yang S, Man Y, Holman BF, Rashidnasab A, Azzopardi G, Grayer M, Simpson JK, Bareille P, Paul L, Woodcock HV, Toshner R, Saunders P, Molyneaux PL, Thielemans K, Wilson FJ, Mercer PF, Chambers RC, Groves AM, Fahy WA, Marshall RP, Maher TM.

Eur Respir J. 2019 Mar 18;53(3). pii: 1801992. doi: 10.1183/13993003.01992-2018. Print 2019 Mar.

PMID:
30765508
6.

Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation.

Coello C, Fisk M, Mohan D, Wilson FJ, Brown AP, Polkey MI, Wilkinson I, Tal-Singer R, Murphy PS, Cheriyan J, Gunn RN.

EJNMMI Res. 2017 Dec;7(1):47. doi: 10.1186/s13550-017-0291-2. Epub 2017 May 25.

7.

Quantification of Lung PET Images: Challenges and Opportunities.

Chen DL, Cheriyan J, Chilvers ER, Choudhury G, Coello C, Connell M, Fisk M, Groves AM, Gunn RN, Holman BF, Hutton BF, Lee S, MacNee W, Mohan D, Parr D, Subramanian D, Tal-Singer R, Thielemans K, van Beek EJ, Vass L, Wellen JW, Wilkinson I, Wilson FJ.

J Nucl Med. 2017 Feb;58(2):201-207. doi: 10.2967/jnumed.116.184796. Epub 2017 Jan 12. Review.

8.

Children and adolescents presenting to chiropractors in Norway: National Health Insurance data and a detailed survey.

Allen-Unhammer A, Wilson FJ, Hestbaek L.

Chiropr Man Therap. 2016 Aug 1;24:29. doi: 10.1186/s12998-016-0107-x. eCollection 2016.

9.

Advanced Analysis of Pharmaco-EEG Data in Humans.

Jobert M, Wilson FJ.

Neuropsychobiology. 2015;72(3-4):165-77. doi: 10.1159/000431096. Epub 2016 Feb 23.

10.

Early Decision-Making in Drug Development: The Potential Role of Pharmaco-EEG and Pharmaco-Sleep.

Wilson FJ, Danjou P.

Neuropsychobiology. 2015;72(3-4):188-94. doi: 10.1159/000382022. Epub 2016 Feb 23. Review.

11.

Learning to identify CNS drug action and efficacy using multistudy fMRI data.

Duff EP, Vennart W, Wise RG, Howard MA, Harris RE, Lee M, Wartolowska K, Wanigasekera V, Wilson FJ, Whitlock M, Tracey I, Woolrich MW, Smith SM.

Sci Transl Med. 2015 Feb 11;7(274):274ra16. doi: 10.1126/scitranslmed.3008438.

PMID:
25673761
12.

Extracting drug mechanism and pharmacodynamic information from clinical electroencephalographic data using generalised semi-linear canonical correlation analysis.

Brain P, Strimenopoulou F, Diukova A, Berry E, Jolly A, Hall JE, Wise RG, Ivarsson M, Wilson FJ.

Physiol Meas. 2014 Dec;35(12):2459-74. doi: 10.1088/0967-3334/35/12/2459. Epub 2014 Nov 17.

PMID:
25402261
13.

Can pharmaco-electroencephalography help improve survival of central nervous system drugs in early clinical development?

Wilson FJ, Leiser SC, Ivarsson M, Christensen SR, Bastlund JF.

Drug Discov Today. 2014 Mar;19(3):282-8. doi: 10.1016/j.drudis.2013.08.001. Epub 2013 Aug 14. Review.

PMID:
23954252
14.

Guidelines for the recording and evaluation of pharmaco-sleep studies in man: the International Pharmaco-EEG Society (IPEG).

Jobert M, Wilson FJ, Roth T, Ruigt GS, Anderer P, Drinkenburg WH, Bes FW, Brunovsky M, Danker-Hopfe H, Freeman J, van Gerven JM, Gruber G, Kemp B, Klösch G, Ma J, Penzel T, Peterson BT, Schulz H, Staner L, Saletu B, Svetnik V; IPEG Pharmaco-EEG Guidelines Committee.

Neuropsychobiology. 2013;67(3):127-67. doi: 10.1159/000343449. Epub 2013 Mar 16.

15.

Validity of physical activity monitors during daily life in patients with COPD.

Rabinovich RA, Louvaris Z, Raste Y, Langer D, Van Remoortel H, Giavedoni S, Burtin C, Regueiro EM, Vogiatzis I, Hopkinson NS, Polkey MI, Wilson FJ, Macnee W, Westerterp KR, Troosters T; PROactive Consortium.

Eur Respir J. 2013 Nov;42(5):1205-15. doi: 10.1183/09031936.00134312. Epub 2013 Feb 8.

16.

Guidelines for the recording and evaluation of pharmaco-EEG data in man: the International Pharmaco-EEG Society (IPEG).

Jobert M, Wilson FJ, Ruigt GS, Brunovsky M, Prichep LS, Drinkenburg WH; IPEG Pharmaco-EEG Guidelines Committee.

Neuropsychobiology. 2012;66(4):201-20. doi: 10.1159/000343478. Epub 2012 Oct 12. Review.

17.

Impact of manufacturing improvements on clinical safety of albumin: Australian pharmacovigilance data for 1988-2005.

Che Y, Wilson FJ, Bertolini J, Schiff P, Maher DW.

Crit Care Resusc. 2006 Dec;8(4):334-8.

PMID:
17227271
18.

One-step analysis of seed storage data and the longevity of Arabidopsis thaliana seeds.

Hay FR, Mead A, Manger K, Wilson FJ.

J Exp Bot. 2003 Mar;54(384):993-1011.

PMID:
12598570
19.

Transmission of Mycobacterium tuberculosis in a rural community, Arkansas, 1945-2000.

Dillaha JA, Yang Z, Ijaz K, Eisenach KD, Cave MD, Wilson FJ, Stead WW, Bates JH.

Emerg Infect Dis. 2002 Nov;8(11):1246-8.

20.

Role of proteolysis and apoptosis in regression of pulmonary vascular remodeling.

Riley DJ, Thakker-Varia S, Wilson FJ, Poiani GJ, Tozzi CA.

Physiol Res. 2000;49(5):577-85.

21.

Vasopressin-induced hypertrophy in H9c2 heart-derived myocytes.

Brostrom MA, Reilly BA, Wilson FJ, Brostrom CO.

Int J Biochem Cell Biol. 2000 Sep;32(9):993-1006.

PMID:
11084379
22.

Expression of matrix-degrading enzymes in pulmonary vascular remodeling in the rat.

Thakker-Varia S, Tozzi CA, Poiani GJ, Babiarz JP, Tatem L, Wilson FJ, Riley DJ.

Am J Physiol. 1998 Aug;275(2):L398-406. doi: 10.1152/ajplung.1998.275.2.L398.

PMID:
9700102
23.

Mast cell collagenase correlates with regression of pulmonary vascular remodeling in the rat.

Tozzi CA, Thakker-Varia S, Yu SY, Bannett RF, Peng BW, Poiani GJ, Wilson FJ, Riley DJ.

Am J Respir Cell Mol Biol. 1998 Apr;18(4):497-510.

PMID:
9533937
24.

Liposome-entrapped antifibrotic agent prevents collagen accumulation in hypertensive pulmonary arteries of rats.

Poiani GJ, Wilson FJ, Fox JD, Sumka JM, Peng BW, Liao WC, Tozzi CA, Riley DJ.

Circ Res. 1992 May;70(5):912-22.

PMID:
1568301
25.
26.

Twice-daily tapering dexamethasone treatment during cranial radiation for newly diagnosed brain metastases.

Weissman DE, Janjan NA, Erickson B, Wilson FJ, Greenberg M, Ritch PS, Anderson T, Hansen RM, Chitambar CR, Lawton CA, et al.

J Neurooncol. 1991 Dec;11(3):235-9.

PMID:
1726656
27.

Vascular connective tissue is rapidly degraded during early regression of pulmonary hypertension.

Tozzi CA, Wilson FJ, Yu SY, Bannett RF, Peng BW, Riley DJ.

Chest. 1991 Mar;99(3 Suppl):41S-42S. No abstract available.

PMID:
1847675
28.

Neuropeptide Y-containing nerves in rat gonads: sex difference and development.

Allen LG, Wilson FJ, Macdonald GJ.

Biol Reprod. 1989 Feb;40(2):371-8.

PMID:
2655723
29.
30.

Increased hemodynamic and survival with endotoxin and septic shock with ibuprofen treatment.

Bone RC, Jacobs ER, Wilson FJ Jr.

Prog Clin Biol Res. 1987;236A:327-32. No abstract available.

PMID:
3303045
31.

Improved immunoelectron microscopic method for localizing cytoskeletal proteins in Lowicryl K4M embedded tissues.

Loesser KE, Doane KJ, Wilson FJ, Roisen FJ, Malamed S.

J Histochem Cytochem. 1986 Nov;34(11):1477-85.

PMID:
3534078
32.

The polysomnographic diagnoses of sleep disorders in elderly medical patients.

Lucas EA, Wooten V, Anderson-Brakhop C, Liem PH, Carter WJ, Wilson FJ Jr, Scheving LE.

Ala J Med Sci. 1986 Apr;23(2):140-5. No abstract available.

PMID:
3706643
33.

Sleep apnea and the Arnold-Chiari malformation.

Balk RA, Hiller FC, Lucas EA, Scrima L, Wilson FJ, Wooten V.

Am Rev Respir Dis. 1985 Oct;132(4):929-30.

PMID:
4051328
34.

Quantitative deposition of ultrafine stable particles in the human respiratory tract.

Wilson FJ Jr, Hiller FC, Wilson JD, Bone RC.

J Appl Physiol (1985). 1985 Jan;58(1):223-9.

PMID:
3968012
35.

Concentration and particle size distribution in smoke from marijuana cigarettes with different delta 9-tetrahydrocannabinol content.

Hiller FC, Wilson FJ Jr, Mazumder MK, Wilson JD, Bone RC.

Fundam Appl Toxicol. 1984 Jun;4(3 Pt 1):451-4.

PMID:
6086435
36.

Shifting granuloma: a sign of lobar collapse.

Webb RT, Beaton JN, Wilson FJ Jr, Hiller FC.

Chest. 1984 Apr;85(4):559-60. No abstract available.

PMID:
6705586
37.
38.

Automatic detection at the polygraph of malposition of the Hewlett-Packard ear oximeter.

Lucas EA, Wilson FJ Jr, Johnson W.

Sleep. 1984;7(3):272-3. No abstract available.

PMID:
6484431
39.

Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin.

Kerwar SS, Englert ME, McReynolds RA, Landes MJ, Lloyd JM, Oronsky AL, Wilson FJ.

Arthritis Rheum. 1983 Sep;26(9):1120-31.

PMID:
6615563
40.

Evaluation and management of acute asthma.

Hiller FC, Wilson FJ Jr.

Med Clin North Am. 1983 May;67(3):669-84.

PMID:
6843223
41.

Immunohistochemical localization of troponin-C in cultured neurons.

Roisen FJ, Wilson FJ, Yorke G, Inczedy-Marcsek M, Hirabayashi T.

J Muscle Res Cell Motil. 1983 Apr;4(2):163-75.

PMID:
6408121
42.

A covalently cross-linked matrix in skeletal muscle fibers.

Loewy AG, Wilson FJ, Taggart NM, Greene EA, Frasca P, Kaufman HS, Sorrell MJ.

Cell Motil. 1983;3(5-6):463-83.

PMID:
6362889
43.

Immunofluorescence localization of contractile proteins in the rat lung following bleomycin injury.

Doane K, McReynolds RA, Wilson FJ.

Histochem J. 1983 Jan;15(1):82-8. No abstract available.

PMID:
6187713
44.

Ibuprofen in canine endotoxin shock.

Jacobs ER, Soulsby ME, Bone RC, Wilson FJ Jr, Hiller FC.

J Clin Invest. 1982 Sep;70(3):536-41.

45.

Haemophilus influenzae infection of an existing lung cyst.

Wewers MD, Hiller FC, Wilson FJ, Bone RC.

South Med J. 1982 Jun;75(6):736-7.

PMID:
6979798
46.

Oculopharyngeal dystrophy: ultrastructure of muscles distinct from the primary myopathy.

Kozachek JW, Wilson FJ.

Acta Neuropathol. 1982;57(1):7-12.

PMID:
7090744
47.

Pulmonary blastomycosis diagnosed by thoracocentesis.

Hargis JL, Bone RC, Miller FC, Wilson FJ.

Chest. 1980 Mar;77(3):455. No abstract available.

PMID:
7357957
49.

Method for sampling airway gas.

Wilson FJ Jr, Bone RC, Hiller FC.

Crit Care Med. 1979 Jul;7(7):307-9.

PMID:
456006
50.

The structure of A segments from glycerinated skeletal muscle.

Irish MJ, Wilson FJ.

Tissue Cell. 1979;11(2):201-7.

PMID:
473156

Supplemental Content

Loading ...
Support Center